ADENOSINE INJECTION DIN 02457482
Health Canada record
| Active ingredient(s) | ADENOSINE 3 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C01EB10 ADENOSINE |
| Original market date | 17-Aug-2017 |
| Current status date | 17-Aug-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Fresenius Kabi Canada Ltd. — licence 102232, currently licensed, last inspection rating C (2025-10-01).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ADENOSINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02457474 | ADENOSINE INJECTION | FRESENIUS KABI CANADA LTD | Solution | ADENOSINE 3 MG | Marketed |
| 02267659 | ADENOSINE INJECTION | FRESENIUS KABI CANADA LTD | Solution | ADENOSINE 3 MG | Marketed |
| 02139308 | ADENOCARD - LIQ RAPID BOLUS IV 3MG/ML | ASTELLAS PHARMA CANADA INC | Solution | ADENOSINE 3 MG | Cancelled Post Market |
| 02145820 | ADENOCARD INJECTION -PRE-FILLED SYRINGE | ASTELLAS PHARMA CANADA INC | Solution | ADENOSINE 3 MG | Cancelled Post Market |
| 02030306 | ADENOCARD LIQ IV 3MG/ML | FUJISAWA PHARMACEUTICAL CO, DIVISION OF FUJISAWA CANADA INC. | Liquid | ADENOSINE 3 MG | Cancelled Post Market |
| 02031078 | ADENOCARD LIQ IV 3MG/ML (PRE-FILLED SYRINGE) | FUJISAWA PHARMACEUTICAL CO, DIVISION OF FUJISAWA CANADA INC. | Liquid | ADENOSINE 3 MG | Cancelled Post Market |
| 02139294 | ADENOSCAN - (FOR IV INFUSION ONLY) | ASTELLAS PHARMA CANADA INC | Solution | ADENOSINE 3 MG | Cancelled Post Market |
| 02401061 | ADENOSINE INJECTION, USP | MYLAN PHARMACEUTICALS ULC | Solution | ADENOSINE 3 MG | Cancelled Pre Market |
| 02409585 | ADENOSINE INJECTION, USP | MYLAN PHARMACEUTICALS ULC | Solution | ADENOSINE 3 MG | Cancelled Pre Market |
| 02402246 | AJ-ADENOSINE | AGILA JAMP CANADA INC | Solution | ADENOSINE 3 MG | Cancelled Pre Market |
| 02410559 | AJ-ADENOSINE | AGILA JAMP CANADA INC | Solution | ADENOSINE 3 MG | Cancelled Pre Market |
| 02243435 | PMS-ADENOSINE | PHARMASCIENCE INC | Solution | ADENOSINE 3 MG | Cancelled Post Market |
International API supply for ADENOSINE
4 valid EDQM Certificates of Suitability from 4 holders. 13 active FDA Drug Master Files.
Request a quote for ADENOSINE INJECTION